CSIMarket Company Name, Ticker, Competitors, else..


Eli Lilly And Company  (LLY)
Other Ticker:  
 

Eli Lilly And Company

LLY's Fundamental analysis



Looking into Eli Lilly growth rates, revenue grew by 36.84 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 613

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.77 %

Eli Lilly faced net loss in contrast to the net income a year ago in III. Quarter 2023

• More on LLY's Growth


Eli Lilly
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Eli Lilly realized cash outflow of $ -0.26per share in trailing twelve-month period.
Company
106.46
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.51.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.85.


• More on LLY's Valuation
 
 Total Debt (Millions $) 20,168
 Dividend TTM ($) 4.36 $
 Dividend Yield TTM (%) 0.77 %
 Revenue/Employee (TTM) $ 916,357
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.26
 Tangible Book Value (Per Share $) 0.49

Eli Lilly
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Eli Lilly realized cash outflow of $ -0.26per share in trailing twelve-month period.
Company
106.46
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.51.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.85.

Eli Lilly Price to Book Ratio is at 46.83 lower than Indusry Avg. of 1127.16. and lower than S&P 500 Avg. of 1608.29

• More on LLY's Valuation

•  Market Capitalization (Millions $) 529,487
•  Shares Outstanding (Millions) 900
•  Employees 35,000
•  Revenues (TTM) (Millions $) 32,073
•  Net Income (TTM) (Millions $) 4,988
•  Cash Flow (TTM) (Millions $) -237
•  Capital Exp. (TTM) (Millions $) -2,878
•  Total Debt (Millions $) 20,168
•  Dividend TTM ($) 4.36 $
•  Dividend Yield TTM (%) 0.77 %
•  Revenue/Employee (TTM) $ 916,357
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.26
•  Tangible Book Value (Per Share $) 0.49

•  Market Capitalization (Millions $) 529,487
•  Shares Outstanding (Millions) 900
•  Employees 35,000
•  Revenues (TTM) (Millions $) 32,073
•  Net Income (TTM) (Millions $) 4,988
•  Cash Flow (TTM) (Millions $) -237
•  Capital Exp. (TTM) (Millions $) -2,878


    LLY's Profitability Comparisons
Eli Lilly achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2023 to 36.06 % from 25.57 % in II. Quarter.




Profitability by Segment



  Ratio
•   Capital Ratio (MRQ) 2.2
•  Total Debt to Equity (MRQ) 1.78
•  Tangible Leverage Ratio (MRQ) 75.52
•  Asset Turnover Ratio (TTM) 0.6
•  Inventory Turnover Ratio (TTM) 1.48



Eli Lilly achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2023 to 36.06 % from 25.57 % in II. Quarter.



• More on LLY's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com